prolaris testing in men with clinically localized prostate cancer
Published 9 years ago • 777 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
1:23
genomic testing impacts treatment decisions in prostate cancer
-
2:03
considering genetic testing in patients with prostate cancer
-
1:04
dr. brawer on the results of the prolaris test for patients with prostate cancer
-
1:06
genetic testing plays larger role in treatment of prostate cancer
-
20:52
aua/astro/suo guidelines on clinically localized prostate cancer
-
2:21
validates ability of myriad genetics’ prolaris test
-
2:38
dr. mason discusses the protect study in localized prostate cancer
-
56:21
genetic testing for prostate cancer: advances and considerations | webinar | ambry genetics
-
1:47:19
genetic testing in prostate cancer webcast (2021)
-
24:52
genetic testing & targeted therapy (for prostate cancer) | leanne burnham, phd | the patient story
-
3:50
detection and risk stratification of localized prostate cancer
-
1:57:03
aua2019 013ic: genetic testing in prostate cancer
-
1:34
nccn guidelines for genetic testing in prostate cancer
-
2:26
genomic testing: a precision-medicine approach applied to early-stage prostate cancer
-
2:01:09
incorporating genomic testing for prostate cancer into your practice webcast (2022)
-
45:40
dr. douglas scherr - surgery for localized prostate cancer
-
15:41
dr. concepcion - genetic testing and prostate cancer 1
-
4:12
active surveillance in localized prostate cancer
-
44:13
prostate cancer: navigating complex treatment landscapes in oncology